European Healthtech startup funding raised during 2024.
In 2024, 411 European Healthtech companies raised a combined €5.2B across 424 funding rounds. UK led by capital raised, and High-Tech Gründerfonds (HTGF) was the most active investor. Data as of 21 Aug 2026.
| Company | Stage | Date | Amount |
|---|---|---|---|
| Bicycle Therapeutics | Other | May 2024 | €512M |
| Cimeio Therapeutics | Other | Dec 2024 | €282M |
| ŌURA | Series D+ | Dec 2024 | €192M |
| Flo Health | Series C |
33 exits · €573M disclosed.
| Calypso Biotech | Acquisition | Jan 2024 | €425M |
| Sonio | Acquisition | May 2024 | €86M |
| Lamidey Noury Medical | Acquisition | Nov 2024 | €50M |
| Apotea | Acquisition | Jan 2024 | €12M |
| Jul 2024 |
| €185M |
| Caresyntax | Series C | Aug 2024 | €164M |
| MMI | Series C | Feb 2024 | €102M |
| Citryll | Series B | Dec 2024 | €85M |
| Agomab Therapeutics | Series D+ | Oct 2024 | €83M |
| Antag Therapeutics | Series A | Dec 2024 | €80M |
| iOnctura | Series B | Jun 2024 | €80M |
| Huma | Series D+ | Jul 2024 | €73M |
| ŌURA | Series D+ | Nov 2024 | €71M |
| Cradle | Series B | Nov 2024 | €69M |
| Nuclera | Series A | Oct 2024 | €69M |
| Neo Medical | Other | Sep 2024 | €61M |
